Caprelsa and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 12 people who take Caprelsa and Zofran. Common interactions include balance disorder among females, and hot flush among males.

The phase IV clinical study analyzes what interactions people who take Caprelsa and Zofran have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 30, 2023

12 people who take Caprelsa and Zofran together, and have interactions are studied.

What is Caprelsa?

Caprelsa has active ingredients of vandetanib. Currently, eHealthMe is studying from 1,150 Caprelsa users.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is used in nausea. Currently, eHealthMe is studying from 90,671 Zofran users.

Number of Caprelsa and Zofran reports submitted per year:

Common Caprelsa and Zofran drug interactions by gender *:

female:

Balance disorder
Bone pain
Cognitive disorder
Constipation
Decreased appetite
Fall
Gastric ulcer
Hernia
Hypersomnia
Hypophagia

male:

Hot flush
Intestinal perforation
Rash
Rash maculo-papular

Common Caprelsa and Zofran drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Balance disorder
Bone pain
Cognitive disorder
Constipation
Decreased appetite
Diarrhoea
Fall
Fatigue
Gastric ulcer
Hernia

50-59:

Bacterial infection
Pain in extremity
Feeling jittery
Nervousness
Diarrhoea
Dry mouth
Dry skin
Ear congestion
Onychoclasis
Rash macular

60+:

Diarrhoea
Abdominal pain upper
Feeling jittery
Glossodynia
Headache
Hypoaesthesia oral
Muscle spasms
Nervousness
Onychoclasis
Pain in extremity

Common conditions people have *:

Thyroid Cancer: 10 people, 83.33%
Metastases To Lung (cancer spreads to lung): 4 people, 33.33%
Medullary Thyroid Cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Caprelsa and Zofran?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Caprelsa side effects (1,150 reports)
Zofran side effects (90,671 reports)

Common Caprelsa drug interactions:

Caprelsa and Synthroid: 111 reports

Browse interactions between Caprelsa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zofran drug interactions:

Zofran and Aspirin: 10,735 reports
Zofran and Tylenol: 9,367 reports
Zofran and Prednisone: 8,033 reports
Zofran and Omeprazole: 7,915 reports
Zofran and Protonix: 7,650 reports
Zofran and Ativan: 7,514 reports
Zofran and Vitamin d: 7,404 reports
Zofran and Gabapentin: 7,142 reports
Zofran and Lasix: 6,995 reports
Zofran and Benadryl: 6,668 reports

Browse interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vandetanib and ondansetron hydrochloride (the active ingredients of Caprelsa and Zofran, respectively), and Caprelsa and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Caprelsa and Zofran.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Clonidine Hydrochloride and Metoprolol Succinate drug interaction - a second ago
Deltasone and Abdominal Distension - 4 seconds ago
Imitrex and C-Reactive Protein Increased - 7 seconds ago
Aminocaproic Acid and Robitussin A-C drug interaction - 9 seconds ago
Pentam and Proteinuria Aggravated - 11 seconds ago
Atovaquone and Pepcid Ac drug interaction - 11 seconds ago
Cialis and Levophed drug interaction - 12 seconds ago
Aspirin and Morphabond drug interaction - 12 seconds ago
Pegasys and Hallucination, Auditory - 13 seconds ago
Zomacton and Headache - 14 seconds ago